Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
0.7100
Dollar change
+0.0800
Percentage change
12.70
%
Index- P/E- EPS (ttm)- Insider Own90.47% Shs Outstand188.33M Perf Week12.70%
Market Cap133.71M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float17.94M Perf Month77.54%
Income- PEG- EPS next Q- Inst Own3.93% Short Float0.65% Perf Quarter54.31%
Sales- P/S- EPS this Y- Inst Trans0.16% Short Ratio0.58 Perf Half Y-14.46%
Book/sh0.83 P/B0.85 EPS next Y- ROA- Short Interest0.12M Perf Year-76.49%
Cash/sh0.19 P/C3.69 EPS next 5Y- ROE- 52W Range0.35 - 4.99 Perf YTD38.94%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-85.77% Beta0.39
Dividend TTM- Quick Ratio1.06 Sales past 5Y- Gross Margin- 52W Low102.68% ATR (14)0.08
Dividend Ex-Date- Current Ratio1.41 EPS Y/Y TTM624.41% Oper. Margin0.00% RSI (14)65.53 Volatility14.05% 15.94%
Employees- Debt/Eq0.99 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price5.17
Option/ShortNo / Yes LT Debt/Eq0.66 EPS Q/Q531.34% Payout- Rel Volume0.67 Prev Close0.63
Sales Surprise-21.07% EPS Surprise-36.85% Sales Q/Q- EarningsJan 22 AMC Avg Volume202.51K Price0.71
SMA2016.95% SMA5042.06% SMA200-11.49% Trades Volume136,010 Change12.70%
Mar-05-24 08:00AM
Feb-22-24 05:00PM
Feb-18-24 04:30AM
Feb-16-24 08:20PM
05:36PM
08:00AM Loading…
Feb-14-24 08:00AM
07:50AM
Feb-12-24 08:50AM
Feb-09-24 06:30AM
Feb-08-24 06:10PM
Jan-24-24 04:00PM
Jan-22-24 10:51PM
05:00PM
Jan-08-24 08:00AM
Dec-20-23 04:30PM
04:15PM Loading…
04:15PM
08:56AM
Nov-14-23 08:30AM
Oct-31-23 08:30AM
Oct-26-23 08:30AM
Oct-10-23 08:00AM
Sep-26-23 08:30AM
Sep-20-23 08:00AM
Sep-15-23 08:30AM
Sep-05-23 08:30AM
Aug-24-23 04:15PM
Aug-17-23 08:00AM
Aug-15-23 05:00PM
Aug-10-23 04:30PM
Jul-26-23 05:00PM
04:30PM Loading…
Jul-21-23 04:30PM
Jun-09-23 08:00AM
Jun-08-23 01:45PM
Jun-01-23 08:30AM
May-18-23 08:25AM
May-16-23 07:00AM
Apr-18-23 07:00AM
Mar-27-23 06:00AM
YS Biopharma Co. Ltd. engages in discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People's Republic of China and Other Countries or Regions. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in Beijing, China.